Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,043,000 | 1,092,000 | 1,052,000 | 719,000 | 2,853,000 |
| Marketable Securities | 19,434,000 | 8,860,000 | 6,048,000 | 11,209,000 | 9,837,000 |
| Receivables | 11,463,000 | 14,451,000 | 11,393,000 | 10,989,000 | 11,566,000 |
| Inventories | 10,851,000 | 11,721,000 | 11,447,000 | 10,892,000 | 10,189,000 |
| Other current assets | 7,567,000 | 7,099,000 | 7,885,000 | 8,606,000 | 8,888,000 |
| TOTAL | $50,358,000 | $43,223,000 | $37,825,000 | $42,415,000 | $43,333,000 |
| Non-Current Assets | |||||
| PPE Net | 18,393,000 | 18,541,000 | 18,957,000 | 18,803,000 | 18,940,000 |
| Investments And Advances | 2,228,000 | 10,762,000 | 11,148,000 | 11,613,000 | 15,368,000 |
| Intangibles | 123,938,000 | 128,556,000 | 129,685,000 | 132,126,000 | 132,683,000 |
| Other Non-Current Assets | 18,479,000 | 18,395,000 | 18,577,000 | 16,139,000 | 16,177,000 |
| TOTAL | $163,038,000 | $176,254,000 | $178,367,000 | $178,681,000 | $183,168,000 |
| Total Assets | $213,396,000 | $219,476,000 | $216,193,000 | $221,095,000 | $226,501,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,946,000 | 9,699,000 | 11,944,000 | 8,232,000 | 10,350,000 |
| Accounts payable and accrued liabilities | 5,633,000 | 5,314,000 | 5,106,000 | 5,591,000 | 6,710,000 |
| Accrued Expenses | 3,838,000 | 3,383,000 | 2,566,000 | 2,192,000 | 2,776,000 |
| Other current liabilities | 19,720,000 | 19,917,000 | 16,410,000 | 18,788,000 | 20,537,000 |
| TOTAL | $42,995,000 | $43,211,000 | $43,819,000 | $40,497,000 | $47,794,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,405,000 | 58,002,000 | 57,506,000 | 61,307,000 | 61,538,000 |
| Deferred Revenues | 1,511,000 | 2,020,000 | 2,528,000 | 2,502,000 | 2,700,000 |
| Other Non-Current Liabilities | 22,369,000 | 23,539,000 | 24,660,000 | 25,793,000 | 27,231,000 |
| TOTAL | $81,904,000 | $83,707,000 | $84,400,000 | $88,039,000 | $89,418,000 |
| Total Liabilities | $124,899,000 | $126,918,000 | $128,218,000 | $128,537,000 | $137,213,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,667,340 | 5,666,990 | 5,666,695 | 5,666,593 | 5,646,778 |
| Common Shares | 480,000 | 480,000 | 480,000 | 480,000 | 478,000 |
| Retained earnings | 116,725,000 | 121,059,000 | 116,596,000 | 121,318,000 | 118,353,000 |
| Other shareholders' equity | -7,548,000 | -7,698,000 | -7,541,000 | -7,482,000 | -7,687,000 |
| TOTAL | $88,497,000 | $92,558,000 | $87,975,000 | $92,558,000 | $89,288,000 |
| Total Liabilities And Equity | $213,396,000 | $219,476,000 | $216,193,000 | $221,095,000 | $226,501,000 |